
RxSight®, based in California, is the pioneer in adjustable intraocular lenses, revolutionizing cataract surgery.
RxSight®, founded in Aliso Viejo, California, is dedicated to transforming the cataract surgery experience. The company's core mission is to revolutionize premium cataract surgery by offering the world's first and only adjustable intraocular lens (IOL) that can be customized post-surgery. Their flagship product, the Light Adjustable Lens™ (LAL®/LAL+™), along with the Light Delivery Device™ (LDD™) system, allows for precise vision adjustments after cataract surgery, catering to patients with corneal astigmatism and without preexisting macular disease.
Notable figures affiliated with RxSight include leading ophthalmologists and industry experts who have contributed to its innovative technology. The company has attracted significant investment from prominent venture capital firms, bolstering its research and development efforts. Key achievements include FDA approval of their adjustable IOL technology and successful commercialization of their products. RxSight's impact on the market is profound, offering a groundbreaking solution that enhances patient outcomes and sets a new standard in cataract surgery.

Clearsight

Sight Sciences
sightsciences.com

ReaLens

Atia Vision
atiavision.com

ReVision Optics
revisionoptics.com

STAAR Surgical
staar.com

OptometRx

Retina Technologies

Adaptilens
adaptilens.com

Elenza
elenza.com

Clerio Vision
cleriovision.com

IrisVision
irisvision.com

Vision Care Connect

Opticent Health
opticenthealth.com

Eyedaptic
eyedaptic.com
Companies similar to RxSight include Clearsight, Sight Sciences, ReaLens and Atia Vision.
RxSight was founded in 1997.
RxSight's headquarters is located in Aliso Viejo, CA, US.
RxSight's most recent funding round was for $50M (USD) in February 2023.
As of Feb 7, 2023, RxSight has raised a total of $236M (USD).
RxSight has 292 employees as of Feb 6, 2024.